Evaxion Biotech A/S (EVAX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.01M | -4.39M | 0 | 0 |
| Operating CF Margin % | - | - | - | - | - | - | - | - | -2749.32% | - | - | - |
| Operating CF Growth % | - | - | - | - | 100% | 100% | - | - | 65.58% | 33.15% | 100% | 100% |
| Net Income | -5.91M | 4.62M | -4.83M | -1.58M | -3.6M | -1.94M | -6.2M | 1.19M | -4.52M | -5.68M | -5.68M | -6.27M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 115K | 200K | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -21K | 100K | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 5.91M | -4.62M | 4.83M | 1.58M | 3.6M | 1.94M | 6.2M | -1.19M | 1.52M | 281K | 5.68M | 6.27M |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 904K | 707K | 0 | 0 |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 707K | 800K | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | -65K | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | -65K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | 1.37% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.26M | 96K | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -118K | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.38M | 96K | 0 | 0 |
| Net Change in Cash | 12.66M | 0 | 0 | 0 | 1.38M | 0 | 0 | 6.15M | 2.98M | -4.51M | -3.12M | -2.94M |
| Free Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.01M | -4.46M | 0 | 0 |
| FCF Margin % | - | - | - | - | - | - | - | - | -2747.95% | - | - | - |
| FCF Growth % | - | - | - | - | 100% | 100% | - | - | 65.23% | 33.07% | 100% | 100% |
| FCF per Share | - | - | - | - | - | - | - | - | -2.94 | -6.44 | - | - |
| FCF Conversion (FCF/Net Income) | - | - | - | - | - | - | - | - | 0.44x | 0.77x | - | - |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |